Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet on Monday, May 12, 2025 at 4:00 P.M. (IST) to discuss the Company's Q4-FY25/FY25 Results
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs Limited has informed the exchanges that it will host an earnings conference call for investors and analysts on Monday, May 12, 2025 at 4:00 P.M. IST. The call will discuss the company's audited financial results for the fourth quarter of FY25 and the full financial year FY25. Top management, including Chairman Rashesh Gogri, Vice Chairperson & Managing Director Hetal Gogri Gala, and CFO Piyush Lakhani, will represent the company. Dial-in numbers for India and international toll-free lines (USA, UK, Singapore, Hong Kong) have been shared. The intimation was filed under SEBI Listing Obligations and Disclosure Requirements (LODR) Regulation 30.
This is a routine procedural announcement with no new financial data or price-moving information disclosed. Investors should watch the call on May 12 for the actual Q4 and FY25 results, management commentary on business outlook, and any guidance that could influence the stock.